Exicure (XCUR) Non-Current Debt (2016 - 2021)
Exicure (XCUR) reported Non-Current Debt of $16.8 million for Q3 2021, up 1.82% on a YoY basis from $16.5 million in Q3 2020, and little changed quarter-over-quarter from $16.7 million in Q2 2021.
Exicure (XCUR) Non-Current Debt (2016 - 2021) Analysis & Trends
Exicure has reported Non-Current Debt for 5 years, with the latest figure at $16.8 million in Q3 2021.
- For the quarter ending Q3 2021, Non-Current Debt rose 1.82% year-over-year to $16.8 million; the trailing twelve-month figure through Sep 2021 stood at $16.8 million (up 1.82% YoY), and the FY2020 full-year result was $16.6 million, changed N/A from the prior year.
- Non-Current Debt for Q3 2021 stood at $16.8 million, roughly flat from $16.7 million in the prior quarter.
- The five-year high for Non-Current Debt was $16.8 million in Q3 2021, with the low at $3.3 million in Q2 2018.
- Historically, Non-Current Debt has averaged $11.2 million across 4 years, with a median of $16.5 million in 2020.
- Annual changes were most pronounced in 2017 — Non-Current Debt gained 9.0% — and 2018, when it climbed 1.44%.
- Exicure's Non-Current Debt stood at $4.9 million in 2017, then advanced by 1.44% to $4.9 million in 2018, then surged by 236.83% to $16.6 million in 2020, then grew by 1.28% to $16.8 million in 2021.
- The last three Non-Current Debt figures came in at $16.8 million (Q3 2021), $16.7 million (Q2 2021), and $16.7 million (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 16.80 Mn |
| Sep 30, 2021 | 16.80 Mn |
| Jun 30, 2021 | 16.73 Mn |
| Jun 30, 2021 | 16.73 Mn |
| Mar 31, 2021 | 16.66 Mn |
| Mar 31, 2021 | 16.66 Mn |
| Dec 31, 2020 | 16.59 Mn |
| Dec 31, 2020 | 16.59 Mn |
| Sep 30, 2020 | 16.50 Mn |
| Sep 30, 2020 | 16.50 Mn |
| Dec 31, 2018 | 4.93 Mn |
| Dec 31, 2018 | 4.93 Mn |
| Jun 30, 2018 | 3.33 Mn |
| Jun 30, 2018 | 3.33 Mn |
| Mar 31, 2018 | 4.10 Mn |
| Mar 31, 2018 | 4.10 Mn |
| Dec 31, 2017 | 4.86 Mn |
| Dec 31, 2017 | 4.86 Mn |
| Dec 31, 2016 | 4.45 Mn |
| Dec 31, 2016 | 4.45 Mn |